Global Ophthalmic Drugs Market size had reached USD 29.46 Billion in 2018, and the market valuation would further appreciate at around 5.1% CAGR during the forecast period (2019 to 2025). The Global Ophthalmic Drugs Market is witnessing rapid increase over the past few years, mainly due to the rising prevalence of eye-related diseases & disorders. Also, discoveries of several breakthrough medicines are significant driving forces leading the growth of the market. Recent advances in medical technologies such as AMPPLIFY technology that demonstrates higher delivery of a drug into ocular tissues are escalating the market on the global platform.
Substantial R&D investments into drug discoveries are another major tailwind pushing the market growth excellently, bringing about novel medicines to treat various ophthalmic diseases. Furthermore, recent development & commercialization of several drugs boost the market growth.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/5753
Also, the improving regulatory framework fosters market growth to an extent. The prevalence of eye-related diseases and disorders, alongside the growing incidences of chronic diseases such as neurovascular or diabetes that affect the eyesight, is rising continually. Moreover, coronary and other retina-related diseases led by the rising numbers of lifestyle diseases such as diabetes are growing too. All these factors are doubling the size of the ophthalmology industry, creating tremendous market demand.
Conversely, factors such as the lengthy approval process for new drug applications, clinical trials, and final approval are impeding the growth of the market significantly. Nevertheless, the demand for sophisticated medications by physicians as well as patients, would, in turn, support the market growth throughout the forecast period.
Global Ophthalmic Drugs Market Segments
The report has been segmented into five major dynamics.
By Dosage Form, the ophthalmic drugs market is segmented into Eye Drops, Ointments, Solutions, Gels, Capsules & Tablets, and others.
By Product Type, the ophthalmic drugs market is segmented into Prescription Drug and OTC Drug.
By Drug Class, the ophthalmic drugs market is segmented into Antibiotics, Anti-Inflammatory, Anti-Glaucoma, and others.
By Indication, the ophthalmic drugs market is segmented into Glaucoma, Retinal Disorder, Dry Eye, Eye Allergy, and others.
Ophthalmic Drugs Market Regional Analysis
North America leads the global ophthalmic drugs heading with the presence of the many major players and a large patient population suffering from eye diseases. Moreover, the availability of well-developed technology and high healthcare expenditures, alongside the rising prevalence of eye diseases in the region, drives the market growth significantly.
Also, the growing demand for eye care led by the increasing numbers of patients suffering from chronic diseases such as diabetes, neurovascular, and different eye disorders impacts market growth positively. Additionally, augmenting demand for the minimally invasive & technologically advanced treatments, alongside the governmental support for R&D funding are expected to drive the regional market growth, commutatively.
Europe’s ophthalmic drugs market is proliferating rapidly. The burgeoning pharmaceutical industry in the region is a major driving force behind the regional market. Besides, factors such as well-penetrated healthcare sectors, a growing number of advanced treatment facilities, and increasing healthcare expenditures in the region are supporting the regional market growth. The European ophthalmic drugs market is expected to demonstrate healthy growth during the review period.
The Asia Pacific ophthalmic drugs market is growing rapidly, mainly due to the development of breakthrough medicines for the treatment of eye diseases. Besides, the rising prevalence of various eye diseases among the growing population, and large unmet needs, offer many growth opportunities for the market players.
Additionally, substantial funding support to drive R&D activities for drug discoveries from the private & public sectors supports the growth of the regional market. Furthermore, growing pharmaceutical industries, alongside the availability of new treatment methods, push the market growth, meeting the ever-increasing demand for eye care in the region.
Ophthalmic Drugs Market Competitive Landscape
The ophthalmic drugs market appears highly competitive and fragmented with several well-established players churning the market competition. To gain a larger competitive advantage in this market, players adopt strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product & technology launch try. These players invest substantially to meet their goals of innovation and increase the footprints.
Ophthalmic Drugs Market Major Players:
Players leading the ophthalmic drugs market include Allergan Plc, Novartis AG, F. Hoffmann-La Roche AG, Bausch Health Companies Inc., Bayer AG, Pfizer Inc., Merck & Co., Inc., Aerie Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc., and Santen Pharmaceutical Co., Ltd., among others.
Ophthalmic Drugs Industry/Innovation/Related News:
Genix Pharmaceuticals Corporation (Canada), a leading pharmaceutical company, announced the completion of the purchase of rights to 30 generic ophthalmic drugs and product dossiers from the TSX Venture Exchange, a stock exchange in Canada. The acquisition represents a milestone for the Company to continue to enhance its portfolio of high growth, high margin pharmaceutical, and nutraceutical products.
Table Of Contents:
1. REPORT PROLOGUE
2. Ophthalmic Drugs Market Introduction
2.2. Scope Of The Study
2.2.1. Research Objective
3. Ophthalmic Drugs Market Research Methodology
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
4. Ophthalmic Drugs Market Dynamics
Browse More Details at: https://www.marketresearchfuture.com/reports/ophthalmic-drugs-market-5753
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312